These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18832778)

  • 21. Prognostic value of myocardial damage markers in patients with chronic heart failure with atrial fibrillation.
    Otaki Y; Arimoto T; Takahashi H; Kadowaki S; Ishigaki D; Narumi T; Honda Y; Iwayama T; Nishiyama S; Shishido T; Miyashita T; Miyamoto T; Watanabe T; Kubota I
    Intern Med; 2014; 53(7):661-8. PubMed ID: 24694473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy.
    Komamura K; Sasaki T; Hanatani A; Kim J; Hashimura K; Ishida Y; Ohkaru Y; Asayama K; Tanaka T; Ogai A; Nakatani T; Kitamura S; Kangawa K; Miyatake K; Kitakaze M
    Heart; 2006 May; 92(5):615-8. PubMed ID: 16387818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.
    Tsutamoto T; Sakai H; Nishiyama K; Tanaka T; Fujii M; Yamamoto T; Horie M
    Circ J; 2007 Dec; 71(12):1873-8. PubMed ID: 18037739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.
    Matsubara J; Sugiyama S; Nozaki T; Akiyama E; Matsuzawa Y; Kurokawa H; Maeda H; Fujisue K; Sugamura K; Yamamoto E; Matsui K; Jinnouchi H; Ogawa H
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25012287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurements of baseline and follow-up concentrations of cardiac troponin-T and brain natriuretic peptide in patients with heart failure from various etiologies.
    Taniguchi R; Sato Y; Nishio Y; Kimura T; Kita T
    Heart Vessels; 2006 Nov; 21(6):344-9. PubMed ID: 17143708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.
    Sabatine MS; Morrow DA; de Lemos JA; Gibson CM; Murphy SA; Rifai N; McCabe C; Antman EM; Cannon CP; Braunwald E
    Circulation; 2002 Apr; 105(15):1760-3. PubMed ID: 11956114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure.
    Zairis MN; Tsiaousis GZ; Georgilas AT; Makrygiannis SS; Adamopoulou EN; Handanis SM; Batika PC; Prekates AA; Velissaris D; Kouris NT; Mytas DZ; Babalis DK; Karidis KS; Foussas SG
    Int J Cardiol; 2010 Jun; 141(3):284-90. PubMed ID: 19157603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistently increased serum concentration of heart-type fatty acid-binding protein predicts adverse clinical outcomes in patients with chronic heart failure.
    Niizeki T; Takeishi Y; Arimoto T; Nozaki N; Hirono O; Watanabe T; Nitobe J; Miyashita T; Miyamoto T; Koyama Y; Kitahara T; Suzuki S; Sasaki T; Kubota I
    Circ J; 2008 Jan; 72(1):109-14. PubMed ID: 18159110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
    Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Predictive value for long term cardiac events by admission B-type natriuretic peptide and pulmonary capillary wedge pressure in patients with chronic heart failure].
    Hu YM; Wang M; Zhao SQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):786-9. PubMed ID: 19102857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of tissue Doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic Peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Bistola V; Parissis JT; Paraskevaidis I; Panou F; Nikolaou M; Ikonomidis I; Flessas N; Filippatos G; Iliodromitis E; Kremastinos DT
    Am J Cardiol; 2010 Jan; 105(2):249-54. PubMed ID: 20102927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum levels of fatty acid-binding protein and brain natriuretic peptide in children with pneumonia complicated by acute congestive heart failure].
    Wang WD; Sun YP; Cui XQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):304-6. PubMed ID: 18554454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.
    McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
    Am J Cardiol; 2009 Jan; 103(1):22-8. PubMed ID: 19101224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism.
    Naito A; Tanabe N; Jujo T; Shigeta A; Sugiura T; Sakao S; Ishida K; Tatsumi K
    PLoS One; 2014; 9(11):e113086. PubMed ID: 25412085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea.
    Harrison A; Morrison LK; Krishnaswamy P; Kazanegra R; Clopton P; Dao Q; Hlavin P; Maisel AS
    Ann Emerg Med; 2002 Feb; 39(2):131-8. PubMed ID: 11823766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.
    Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS
    BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of pentraxin-3 level in patients with STEMI and its relationship with heart failure and markers of oxidative stress.
    Tomandlova M; Jarkovsky J; Tomandl J; Kubkova L; Kala P; Littnerova S; Gottwaldova J; Kubena P; Ganovska E; Poloczek M; Spinar J; Mueller C; Mebazaa A; Pavkova Goldbergova M; Parenica J
    Dis Markers; 2015; 2015():159051. PubMed ID: 25922551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reevaluation of cardiac risk scores and multiple biomarkers for the prediction of first major cardiovascular events and death in the drug-eluting stent era.
    Onda T; Inoue K; Suwa S; Nishizaki Y; Kasai T; Kimura Y; Fukuda K; Okai I; Fujiwara Y; Matsuoka J; Sumiyoshi M; Daida H
    Int J Cardiol; 2016 Sep; 219():180-5. PubMed ID: 27327504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated plasma level of pentraxin-3 predicts in-hospital and 30-day clinical outcomes in patients with non-ST-segment elevation myocardial infarction who have undergone percutaneous coronary intervention.
    Guo R; Li Y; Wen J; Li W; Xu Y
    Cardiology; 2014; 129(3):178-88. PubMed ID: 25323314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart-type fatty acid-binding protein and myocardial creatine kinase enable rapid risk stratification in normotensive patients with pulmonary embolism.
    Langer M; Forkmann M; Richter U; Tausche AK; Sveric K; Christoph M; Ibrahim K; Günther M; Kolschmann S; Boscheri A; Barthel P; Strasser RH; Wunderlich C
    J Crit Care; 2016 Oct; 35():174-9. PubMed ID: 27481755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.